This page covers how that clinical diagnosis is actually made, which blood tests tend to be ordered and what each one is looking for, why a completely normal panel is the expected result, and when symptoms are worth bringing to a clinician promptly.
No. No laboratory test, imaging study or biopsy confirms fibromyalgia, and the diagnosis is made clinically from the pattern, spread and duration of symptoms alongside a physical examination 2.
The criteria clinicians work from are built on symptoms, not on numbers from a tube of blood. The 2016 revision of the widely used diagnostic criteria asks where pain is felt across defined body regions, how long it has been present and how severe the accompanying fatigue, sleep and cognitive symptoms are 1.
That catches people off guard. A condition that produces this much pain feels like it ought to leave a mark somewhere measurable. In fibromyalgia it generally does not, because the problem sits in how pain signals are processed rather than in visible damage to joints, muscle or bone.
So what does that mean in practice? Blood tests still get ordered, but their job is different from what most people assume. They are not confirming anything. They are checking that something else, something that does show up in bloodwork, is not driving the symptoms instead. If you are preparing for an appointment, the most valuable preparation is a clear account of where it hurts, how long it has hurt, and what it does to your sleep and concentration, rather than a search for a test that does not exist.
Fibromyalgia is a long-term condition of widespread body pain accompanied by fatigue, unrefreshing sleep and difficulty with memory or concentration.
One widely used framework defines it as pain at six or more of nine possible body sites, together with moderate to severe sleep problems or fatigue, present for at least three months 3. Unrefreshing sleep is associated with fibromyalgia closely enough that it sits in those criteria alongside the pain itself 3.
The pain is usually described as deep, aching and moving, rather than confined to one joint. Many people also report headaches, abdominal symptoms, sensitivity to noise, light or cold, and a mental fog that makes words and names harder to retrieve. None of these are specific on their own, which is why the combination and the duration matter more than any single complaint.
Fibromyalgia is also not an either-or diagnosis. Someone can have an inflammatory or autoimmune condition and fibromyalgia at the same time, and the current criteria explicitly allow the diagnosis to stand alongside other conditions 1.
They apply published symptom criteria to a careful history, add a physical examination, and order a short, targeted set of blood tests to exclude other explanations.
Under the 2016 revised criteria, the requirements are generalised pain affecting at least four of five body regions, symptoms present at a similar level for at least three months, and scores above set thresholds on two scales, a widespread pain index and a symptom severity scale 1. The widespread pain index counts painful areas from a defined list, and the symptom severity scale rates fatigue, waking unrefreshed and cognitive symptoms, along with a small set of other somatic symptoms 5.
In a consultation this usually looks like a body map you mark up, a few scaled questions about sleep and tiredness, and questions about how long each symptom has lasted. It is quick, and it does more diagnostic work than any panel of bloods.
The physical examination is mostly looking for what is absent. A clinician checks for swollen or hot joints, muscle weakness, rashes, enlarged lymph nodes and neurological signs. Fibromyalgia produces tenderness, often widely, but it does not produce joint swelling or objective weakness. When those findings are present, the workup turns toward a different explanation.
Observation, meaning, next step. The observation is a symptom pattern plus an unremarkable examination. The meaning may be fibromyalgia, or it may be an early presentation of something else. The next step is the short laboratory panel described below, interpreted by the clinician who examined you.
It was moved out of the main diagnostic criteria in 2010, replaced by symptom scores that a clinician can apply without pressing on specific anatomical points 5.
The earlier 1990 criteria relied on a count of tender points, with a threshold of 11 out of 18 defined sites, and that examination turned out to be difficult to perform consistently from one clinician to the next 6. Pressure applied varied, patient responses varied on different days, and many clinicians outside rheumatology never performed the count at all.
Research suggests that a symptom-based score classifies most people previously identified under the older approach without any tender point examination 5. The later revision kept that direction of travel and added a self-report version of the questions, which allows the information to be gathered before the appointment 1.
For you, this has two practical consequences. First, if a clinician does not press on your shoulders and hips, that is not a shortcut, it reflects the current criteria. Second, your own description of where and how much it hurts now carries more diagnostic weight than any manoeuvre performed in the room. Writing it down before you go in is genuinely useful, because the scales ask about regions and severity, which are easy to underestimate on a good day and overstate on a bad one.
Because several conditions produce near-identical symptoms and are found only in blood, and because a diagnosis that rests on symptoms alone is more secure once those have been cleared.
Fibromyalgia sits in an unusual position. It is partly a diagnosis of exclusion, since look-alike conditions have to be considered, and partly a diagnosis of inclusion, since positive criteria must also be met 7. Bloodwork serves the exclusion half of that job and contributes nothing to the inclusion half.
There is a second reason. Fatigue, aching and fog are common endpoints for very different problems, including anaemia, thyroid dysfunction, nutrient deficiency, disturbed sleep and early inflammatory disease. Some of those are straightforward to identify. Leaving them unexamined means a person may carry a fibromyalgia label while a separate, identifiable contributor goes unaddressed.
The counterweight is that testing can be overdone. A targeted panel is recommended rather than a sprawling search, because repeated rounds of inconclusive investigation delay the diagnosis and the support that follows it 2.
A reasonable expectation to walk in with is this. The bloods will probably be normal, normal is informative, and normal does not mean nothing is wrong.
A short, targeted panel aimed at the conditions that most often mimic fibromyalgia, typically a blood count, inflammatory markers, thyroid function and a few others guided by your examination 2.
| Test | What it measures | Why a clinician may order it |
|---|---|---|
| Complete blood count | Red cells, white cells and platelets | Picks up anaemia or signs of infection that can explain fatigue and aching |
| C-Reactive Protein | A liver protein that rises with inflammation | Screens for an inflammatory process that fibromyalgia itself does not generate |
| Erythrocyte sedimentation rate | How fast red cells settle in a tube | A second, slower inflammation signal that can flag inflammatory or autoimmune disease |
| Thyroid-stimulating hormone | The pituitary signal to the thyroid gland | An underactive thyroid can mimic fatigue, aching, cold intolerance and cognitive fog |
| Vitamin D, as 25-hydroxyvitamin D | Circulating vitamin D status | Low levels can present as diffuse bone and muscle pain |
| Creatine kinase | An enzyme released by damaged muscle | Separates muscle disease from the muscle pain of fibromyalgia |
| Antinuclear antibody | Antibodies directed at cell nuclei | Ordered when specific features suggest autoimmune disease, not as a routine screen |
The differential for diffuse musculoskeletal pain is wide, and a focused set of tests chosen around the examination findings has long been the recommended approach rather than a broad fishing expedition 8.
Which of these you are offered is a clinical decision made by the person who examined you, and the list may be shorter or longer depending on your age, your history and what the examination showed.
C-Reactive Protein is a protein released by the liver when inflammation is present anywhere in the body, measured from an ordinary blood draw. It is a general inflammation signal, not a fibromyalgia test, and in fibromyalgia laboratory results including inflammatory markers are characteristically normal 2. A typical lab reference range is 0 to 3 mg/L, while FitScript's optimal range is 0 to 1 mg/L. Reference ranges vary by lab, age and sex, and an optimal range is an optimisation target rather than a diagnostic cut-off. A raised value suggests inflammation somewhere and is worth discussing with a clinician, who decides whether it redirects the workup.
The esr measures how quickly red blood cells settle to the bottom of a tube over an hour, which rises indirectly when inflammatory proteins are circulating.
It moves more slowly than C-Reactive Protein in both directions, which makes it useful for picking up a smouldering inflammatory process that has been present for weeks. Clinicians often run the two together because they respond to different things and a discrepancy between them is itself informative.
An elevated sedimentation rate may reflect inflammatory arthritis, an autoimmune condition, infection, anaemia or, in older adults, a vessel inflammation that needs prompt attention. It also drifts upward with age and is higher on average in women, which is why a single mildly raised value is interpreted in context rather than treated as an alarm.
In fibromyalgia, this marker is typically unremarkable. That is the point of ordering it. A normal sedimentation rate alongside a normal C-Reactive Protein makes an active inflammatory disease less likely, which strengthens the case for a symptom-based diagnosis.
Observation, meaning, next step. The observation is a number above the lab's cut-off. The meaning may be inflammation, may be age or anaemia, and cannot be pinned down from the value alone. The next step is a conversation with the clinician who ordered it, who will weigh it against your examination findings, and a meaningfully raised result alongside fever, weight loss or new morning stiffness is worth discussing promptly rather than at the next routine visit.
Because an underactive thyroid produces fatigue, muscle aching, stiffness, cold intolerance, low mood and slowed thinking, a cluster that overlaps heavily with fibromyalgia and is identified with a simple blood test.
tsh, thyroid-stimulating hormone, is the usual first-line measurement. It is the pituitary gland's signal to the thyroid, and it rises when the thyroid is underperforming, which makes it a sensitive early indicator. Depending on the result, a clinician may add free thyroxine or thyroid antibodies to clarify the picture.
This is one of the more valuable tests in the fibromyalgia workup precisely because the symptom overlap is so close and the finding is so actionable. It is also one of the easier ones to misread. A single out-of-range value can reflect a recent illness, so a repeat test is often requested before any conclusion is drawn.
The two conditions are not mutually exclusive either. Someone can have reduced thyroid function and fibromyalgia, and improving one does not necessarily resolve the other. That is why a clinician reassesses symptoms after thyroid function has been addressed rather than assuming the whole picture is explained.
Any decision about what to do with an abnormal thyroid result, including whether any therapy is appropriate, belongs to a licensed provider who has reviewed your full history. Nothing on this page substitutes for that assessment.
Vitamin D is checked because low levels are common and can present as diffuse aching in bone and muscle, along with fatigue, which is hard to tell apart from fibromyalgia on symptoms alone.
vitamin d is measured as 25-hydroxyvitamin D, the circulating storage form, which reflects status over the preceding weeks rather than the last few days. Levels fall with limited sun exposure, darker skin pigmentation, higher body weight, malabsorption and reduced outdoor time, all of which are more likely in someone whose pain has restricted their activity.
There is a loop worth noticing here. Widespread pain reduces time outdoors and exercise, lower activity and sun exposure are plausible contributors to falling vitamin D, and low vitamin D can add its own layer of musculoskeletal aching on top of the original problem. Untangling which came first is rarely possible, and it rarely matters clinically, because the finding is worth addressing either way.
Observation, meaning, next step. A low result tells you one contributor to body aches is present. It does not tell you fibromyalgia is absent, and correcting it does not reliably resolve widespread pain. Whether anything should be done about a low level, and what, is a decision for a clinician who can see your other results and history. This page does not offer guidance on supplementation of any kind.
Creatine kinase looks for genuine muscle damage, and antinuclear antibody testing looks for autoimmune disease, two categories that can present with pain and weakness but behave very differently from fibromyalgia.
Creatine kinase is an enzyme that leaks into the blood when muscle fibres are injured. Fibromyalgia hurts the muscles without damaging them, so this marker stays normal. A clearly elevated value shifts attention toward an inflammatory muscle disease, a metabolic muscle disorder or another cause of muscle breakdown, and it is one of the few results in this panel that can change the whole direction of the workup. Recent intense exercise can raise it temporarily, which is worth mentioning to whoever ordered the test.
Antinuclear antibody testing is more nuanced. It detects antibodies directed at structures inside cell nuclei, and it can be positive in people with no autoimmune disease at all, particularly at low titres and increasingly with age. Ordering it without a specific reason generates more confusion than clarity, which is why it belongs in the workup when there are supporting features such as joint swelling, rashes, mouth ulcers, hair loss or sun sensitivity, rather than as a routine screen.
A positive result on its own does not establish an autoimmune condition. It is interpreted against the examination, the symptom pattern and any further antibody testing a clinician may add. If your result comes back positive, the useful question to ask is what specific features, if any, support it.
Several, which is precisely why the limited laboratory panel exists. The differential for chronic widespread musculoskeletal pain includes inflammatory, endocrine, metabolic and sleep-related causes 8.
The common imitators fall into a few groups. Endocrine causes include an underactive thyroid. Inflammatory and autoimmune causes include rheumatoid arthritis, lupus, and in older adults polymyalgia rheumatica, which produces shoulder and hip girdle pain with morning stiffness and usually raised inflammatory markers. Haematological and nutritional causes include anaemia and vitamin D deficiency. Muscle disorders show up through creatine kinase. Sleep disorders, particularly obstructive sleep apnoea, generate unrefreshing sleep, fatigue and cognitive fog that mirror fibromyalgia closely.
Mood disorders also overlap, in both directions. Persistent pain disturbs mood and sleep, and low mood amplifies the experience of pain. Separating cause from consequence is often not possible, and a clinician will usually address both rather than choose between them.
What distinguishes fibromyalgia on examination is the absence of objective findings. No joint swelling, no weakness, no rash, no fever, no abnormal bloods, with widespread tenderness and a long symptom history that meets the criteria. When objective findings are present, a different or additional diagnosis is in play, and the more precise diagnosis of fibromyalgia rests on positive criteria rather than on exclusion alone 4.
Coexistence is common enough that finding one of these conditions does not close the question. Both can be true at once.
Some laboratories market panels claiming to identify fibromyalgia from blood, usually based on immune signalling molecules, but no laboratory marker has been established as diagnostic.
Studies suggest that candidate biomarkers examined in fibromyalgia, including markers of pain signalling and stress response, have not reached the standard needed to diagnose the condition in an individual 9. The diagnostic framework used in practice has moved further toward symptom-based assessment rather than toward a laboratory marker 6.
That matters for two practical reasons. A negative commercial panel does not remove a diagnosis that meets the clinical criteria, and a positive one does not establish it. Either way the clinician works from the same criteria, so an out-of-pocket test is unlikely to change the conclusion or the care that follows.
Where broad biomarker testing does earn its place is in the exclusion half of the job, mapping thyroid function, inflammation, blood count and nutrient status in one pass so the look-alike conditions are addressed properly. A FitScript membership includes 150+ biomarkers tested per year, with interpretation from Atlas, the AI health advisor included with the membership, and that breadth can surface contributors to fatigue and aching, though no panel diagnoses fibromyalgia.
If you are considering a marketed fibromyalgia test, it is worth asking the ordering clinician what they would do differently with the result before you pay for it.
Arrive with a written symptom record, because the diagnosis depends far more on what you report than on what the laboratory returns.
Useful things to bring. A body map or simple list of every area that has hurt in the past week, since the criteria count regions rather than overall intensity. How long each symptom has been present, with three months as the threshold that matters. A sense of your sleep, specifically whether you wake unrefreshed rather than just how many hours you sleep. Notes on fatigue and on memory or concentration difficulties. Anything that reliably makes symptoms better or worse, including weather, stress, activity and illness.
Also bring copies of previous blood results if you have them, since a comparison over time is often more informative than a single snapshot, and a list of everything you currently take, including anything bought without a prescription.
For the draw itself, ask the ordering clinician whether fasting is required, because it depends on which tests are included rather than on fibromyalgia. Mention any recent intense exercise, since it can raise creatine kinase, and mention any recent infection, since it can raise inflammatory markers temporarily.
Finally, be prepared for the results to be normal, and decide in advance what you want to ask in that case. A good question is what the normal results have ruled out and what the next step is now.
Normal results are the expected pattern in fibromyalgia, and they do not mean the symptoms are unexplained or that the search has failed.
This is the hardest part of the process to sit with. Having described months of pain, fatigue and fog, a person is handed a page of results that all read normal. The normal panel is doing real work. It has reduced the likelihood of thyroid dysfunction, anaemia, active inflammation, muscle disease and nutrient deficiency, which is what allows a criteria-based diagnosis to be made with confidence rather than by default.
Fibromyalgia is recognised as a condition in its own right under the current criteria, and the diagnosis is valid regardless of whether other conditions are also present 1. It does not require the absence of every other explanation, and it is not a label applied only when nothing else is found.
The constructive next step after a normal panel is to return to the criteria. Ask whether the pain regions, duration and symptom severity meet them, and if they do, ask what the care plan looks like from here. Management involves several components, and treatment decisions belong to a licensed provider who has assessed you directly.
When symptoms include features that fibromyalgia does not produce, because those point toward a different process that benefits from earlier attention.
Features worth raising promptly rather than waiting include fever or night sweats, unintended weight loss, visibly swollen, hot or red joints, new muscle weakness rather than pain, a new rash, prolonged morning stiffness lasting well over an hour, new severe headache with scalp tenderness or jaw pain on chewing, and any new neurological change such as numbness, loss of coordination or bladder or bowel changes. Pain that is sharply localised and progressively worsening, rather than widespread and fluctuating, also deserves separate assessment.
Any result outside the standard reference range should be reviewed with the clinician who ordered it, and a markedly abnormal inflammatory marker, blood count or creatine kinase result is worth discussing promptly. Never set an abnormal result aside because a page like this one described it as common.
It is equally worth making an appointment when nothing dramatic is happening but widespread pain has persisted for three months or more and is affecting sleep, work or mood. That is the threshold at which the diagnostic criteria become applicable, and earlier assessment shortens the uncertainty.
This article is educational and is not medical advice. Discuss your symptoms, your results and any treatment decisions with a clinician or licensed provider who can assess you in person.
No. There is no blood test, scan or biopsy that confirms fibromyalgia, and the diagnosis is made clinically from the pattern, spread and duration of symptoms alongside a physical examination. Bloodwork is ordered to check for other conditions that cause similar symptoms, not to confirm fibromyalgia itself.
A short, targeted panel is typical, commonly a complete blood count, C-Reactive Protein, an erythrocyte sedimentation rate, thyroid-stimulating hormone and vitamin D. Creatine kinase may be added if muscle weakness is present, and an antinuclear antibody test may be added when specific features suggest autoimmune disease. Which tests you are offered is decided by the clinician who examined you.
It depends on which tests are included rather than on fibromyalgia. Inflammatory markers, thyroid function and a blood count do not usually require fasting, but a panel that includes glucose or lipids might. Ask the clinician or the lab when the request is made, and mention any recent intense exercise or recent infection, since both can shift results temporarily.
Normal results are the expected pattern in fibromyalgia and they still carry useful information, because they make several look-alike conditions less likely. The next step is to return to the diagnostic criteria, which are based on where you hurt, for how long, and how severe your fatigue, sleep and cognitive symptoms are. Ask your clinician what the normal results have ruled out and what the plan is from here.
A primary care clinician can make the diagnosis, since it rests on symptom criteria and a physical examination rather than specialist testing. A rheumatologist may be involved when the picture is unclear, when examination findings suggest inflammatory or autoimmune disease, or when another condition needs to be assessed alongside it.
At least three months at a similar level. The duration requirement exists because short-lived widespread pain often has a different cause, such as a recent infection or injury. Keeping a simple dated record of your symptoms makes this part of the assessment much easier.
No laboratory marker has been established as diagnostic for fibromyalgia, so a marketed kit is unlikely to change the conclusion a clinician reaches from the criteria. A negative result does not remove a diagnosis that meets those criteria, and a positive one does not establish it. Before paying out of pocket, ask the clinician what they would do differently with the result.
Yes. The current criteria allow the diagnosis to stand even when another condition is also present, so finding thyroid dysfunction, anaemia or an inflammatory disease does not rule fibromyalgia out. This is why a clinician usually reassesses symptoms after another finding has been addressed, rather than assuming the whole picture is explained.